Illumina (ILMN) stock slides 10% after 2026 outlook puts China, research demand back in focus

Illumina (ILMN) stock slides 10% after 2026 outlook puts China, research demand back in focus

Illumina shares dropped 10.3% to $119.91 after the company forecast 2026 revenue of $4.5–$4.6 billion and non-GAAP EPS of $5.05–$5.20. Management cited progress in China but said approvals are still needed for instrument sales. Fourth-quarter revenue rose 5% to $1.16 billion, with ex-China revenue up 8%. The company expects 2026 organic revenue growth of 2–4% excluding China.
Booking Holdings (BKNG) stock price lags Wall Street rally as AI fears resurface ahead of earnings

Booking Holdings (BKNG) stock price lags Wall Street rally as AI fears resurface ahead of earnings

Booking Holdings shares fell 0.9% to $4,403.52 Friday, trailing gains in the S&P 500 and Nasdaq 100 trackers. Wedbush cut its price target to $5,500, citing AI risks, while Baird called the week’s slide an overreaction. The stock is down 24% from its July high. Booking reports Q4 and full-year results on Feb. 18.
PayPal stock steadies in Friday trade as Wall Street digests CEO shake-up and target cuts

PayPal stock steadies in Friday trade as Wall Street digests CEO shake-up and target cuts

PayPal shares rose 0.8% to $40.23 Friday after a week of losses triggered by weak earnings, a CEO exit, and a gloomy 2026 outlook. Analysts cut price targets and flagged shrinking growth in PayPal’s branded checkout segment. Enrique Lores will become CEO March 1, with interim leadership by CFO Jamie Miller. Former president David Marcus criticized PayPal’s competitiveness as rivals gain ground.
6 February 2026
Molina Healthcare stock dives 27% after 2026 profit outlook reset; Medicare Advantage exit looms

Molina Healthcare stock dives 27% after 2026 profit outlook reset; Medicare Advantage exit looms

Molina Healthcare shares plunged 27% to $129.77 after the company forecast 2026 adjusted EPS of at least $5.00, far below the $13.76 analyst consensus. Management cited higher medical costs and a sharp pullback in ACA Marketplace membership. The company posted a Q4 adjusted loss of $2.75 per share and plans to exit its Medicare Advantage Part D business in 2027.
6 February 2026
Dow hits 50,000 as Amazon’s $200 billion AI spending plan spooks tech investors

Dow hits 50,000 as Amazon’s $200 billion AI spending plan spooks tech investors

The Dow briefly topped 50,000 for the first time Friday as chipmakers surged on AI data-center spending hopes. Amazon shares fell after announcing a $200 billion capital spending plan for 2026, raising concerns about profitability. Nvidia, AMD, and Broadcom each jumped over 7%. The S&P 500 rose 1.73% and the Nasdaq gained 1.91%.
CoreWeave stock price jumps 18% as AI-spending trade rebounds; CRWV earnings date set

CoreWeave stock price jumps 18% as AI-spending trade rebounds; CRWV earnings date set

CoreWeave shares jumped 18.3% to $88.31 Friday, rebounding after two days of steep losses. Trading volume hit 27.7 million by 3 p.m. EST. The surge followed Amazon’s $200 billion data center spending plan and Nvidia’s recent $2 billion investment in CoreWeave. The company also launched its first brand campaign and unveiled a new customer testing lab.
Bitcoin price swings as Bitfinex margin longs hit 2-year high — dip buying, or no bottom yet?

Bitcoin price swings as Bitfinex margin longs hit 2-year high — dip buying, or no bottom yet?

Bitfinex margin long positions in bitcoin reached a two-year high of about 77,100 BTC, up 64% in six months, even as bitcoin briefly fell below $64,000 and over $1 billion in positions were liquidated Thursday, according to CoinDesk and Axios. Bitcoin rebounded above $70,000 Friday, but options traders continued buying downside protection, with demand for puts described as “extreme.”
6 February 2026
Thermo Fisher stock price today: TMO nudges higher after Thursday drop as investors eye next week’s data

Thermo Fisher stock price today: TMO nudges higher after Thursday drop as investors eye next week’s data

Thermo Fisher shares rose 0.6% to $545.58 Friday afternoon, recovering some ground after a 4% drop Thursday. The move lagged the broader market, with the S&P 500 up 1.73%. Investors remain cautious amid weak academic research funding and uncertain lab order trends. Upcoming U.S. jobs and inflation data could affect rate expectations and valuations.
6 February 2026
Amazon’s $200bn AI spending plan spooks investors as AWS runs into Europe power grid delays

Amazon’s $200bn AI spending plan spooks investors as AWS runs into Europe power grid delays

Amazon shares fell 7% to $206.31 Friday after the company projected $200 billion in capital spending for 2026, up sharply from $131 billion in 2025. AWS cited multi-year waits for power-grid connections in Europe as a key obstacle to data center expansion. Investors questioned whether heavy AI and cloud outlays will deliver returns quickly.
Impinj stock dives 24% after outlook whiffs; Evercore slashes rating on PI

Impinj stock dives 24% after outlook whiffs; Evercore slashes rating on PI

Impinj shares fell 24.3% to $116.46 Friday after the company forecast a sharp first-quarter slowdown, citing inventory burn-down in logistics and weaker systems demand. Evercore ISI downgraded the stock and cut its price target to $112. Fourth-quarter revenue came in at $92.8 million, with first-quarter guidance of $71–$74 million. The stock hit an intraday low of $105.
Estee Lauder stock rebounds after brutal earnings selloff as Citi upgrade shifts focus to tariffs

Estee Lauder stock rebounds after brutal earnings selloff as Citi upgrade shifts focus to tariffs

Estee Lauder shares rose about 4% to $100.58 on Friday, recovering part of Thursday’s post-earnings drop. Citi upgraded the stock to “buy,” citing elevated expectations and travel retail disruptions as key factors in the selloff. The company reported fiscal Q2 net sales up 6% to $4.23 billion and reiterated a $100 million tariff hit to annual profit. U.S. demand and tariffs remain major concerns.
VeriSign stock dives nearly 10% after outlook, costs take the shine off results

VeriSign stock dives nearly 10% after outlook, costs take the shine off results

VeriSign shares dropped nearly 10% Friday after its quarterly report, underperforming a rising market. The company raised its dividend and maintained heavy buybacks, but 2026 guidance and .com pricing limits drew scrutiny. Fourth-quarter revenue reached $425 million with net income of $206 million. Post-hearing briefs in the .web arbitration are expected in the first half of 2026.
1 19 20 21 22 23 1,639

Stock Market Today

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

8 February 2026
Tower Semiconductor shares rose 7.7% to $139.04 Friday after announcing a collaboration with Nvidia on AI data-center networking. The stock touched $141 intraday and gained another 1% after hours. Investors await Tower’s Feb. 11 earnings for details on its silicon photonics work. No financial terms or shipment timeline were disclosed.
Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

8 February 2026
Longsys disclosed new guarantees for a 100 million yuan Hong Kong loan and a $9 million Brazil credit line, bringing its total approved guarantee quota to 11 billion yuan and outstanding guarantees to 5.81 billion yuan. The company said all guarantees are for consolidated subsidiaries and within approved limits. Shares closed at 288 yuan Friday, down 1.6%. China inflation and credit data are due this week.
MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

8 February 2026
MACOM shares rose 3.5% to $235.87 Friday after the company reported fiscal Q1 revenue of $271.6 million and raised its full-year data center growth outlook to 35–40%. Fidelity’s FMR LLC disclosed a 10.7% stake, while shareholder Susan Ocampo filed to potentially sell up to 100,000 shares. Stifel raised its price target to $255. MACOM expects to repay $161 million in convertible notes in March.
Go toTop